IQVIA Holdings Inc.
IQVHealthcareNASDAQDiagnostics & Research · Last scanned May 29, 2026
Scan Results
Daily timeframePart of the healthcare sector, IQVIA Holdings Inc. (IQV) is listed under Diagnostics & Research. With a market capitalization of $30.22B, it sits in large-cap territory. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Market Cap
$30.22B
Beta
1.18
P/E (TTM)
22.47
P/E (Fwd)
12.76
EPS (TTM)
$8.06
EPS (Fwd)
$14.19
ROE
22.5%
ROA
5.1%
Cash
$2.10B
Total Debt
$16.22B
Free CF
$2.16B
52W Change
29.0%
Annual Financials
Cash vs Debt
The company holds $2.10B in cash, though total debt stands at $16.22B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $2.16B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 22.5% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $14.41B to $16.31B.
IQVIA Holdings Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing IQV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.